{"id":"W4360610525","doi":"10.1136/rmdopen-2022-002718","title":"Sex differences in the efficacy, safety and persistence of patients with psoriatic arthritis treated with tofacitinib: a post-hoc analysis of phase 3 trials and long-term extension","year":2023,"lang":"en","type":"article","venue":"RMD Open","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Ottawa; Pfizer (Canada); Ottawa Hospital; Toronto Western Hospital; Women's College Hospital; University of Toronto","funders":"Samsung; Genentech; Celltrion; Regeneron Pharmaceuticals; Gilead Sciences; Sanofi; GlaxoSmithKline; Amgen; Pfizer; Kiniksa Pharmaceuticals; Celgene; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Tofacitinib; Internal medicine; Placebo; Discontinuation; Psoriatic arthritis; Rheumatology; Psoriasis Area and Severity Index; Psoriasis; Janus kinase inhibitor; Adalimumab; Post-hoc analysis; Adverse effect; Dactylitis; Arthritis; Physical therapy; Enthesitis; Rheumatoid arthritis; Dermatology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03168814,0.001528276,0.005187254,0.0008596334,0.0004675671,0.001980727,0.001007668,0.001310138,0.007809619],"category_scores_gemma":[0.02667329,0.000571019,0.0198551,0.001017975,0.0008417348,0.001561259,0.001099688,0.001935611,0.0004460019],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007725618,"about_ca_system_score_gemma":0.001273646,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005115496,"about_ca_topic_score_gemma":0.001025143,"domain_scores_codex":[0.975076,0.01808902,0.002032557,0.001894826,0.001860485,0.001047118],"domain_scores_gemma":[0.9623556,0.02568102,0.006752155,0.002653473,0.001455917,0.001101847],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.8465736,0.0004386632,0.02146931,0.002698484,0.1086845,0.000172319,0.000113339,0.0005759692,0.001682839,0.0000876193,0.0008482892,0.01665504],"study_design_scores_gemma":[0.2855914,0.1172471,0.2886956,0.0009276562,0.2926325,0.000704854,0.0003183982,0.00331554,0.003386185,0.0007962784,0.006151344,0.0002330561],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9286081,0.0582296,0.003063271,0.0006375723,0.0007476073,0.002302865,0.003931596,0.0001321396,0.00234721],"genre_scores_gemma":[0.9910582,0.003096002,0.001133087,0.000437249,0.0003207832,0.001499265,0.001419706,0.00006423936,0.0009714847],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03168814,"threshold_uncertainty_score":0.1675849,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05104802132091156,"score_gpt":0.3191608334275893,"score_spread":0.2681128121066777,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}